Green Cross Voluntarily Withdraws Conditional Approval Application for COVID-19 Plasma Treatment Zicoviddic Injection
[Asia Economy Reporter Oh Ju-yeon] Green Cross announced on the 4th that it will voluntarily withdraw its conditional marketing authorization application for the COVID-19 plasma treatment Zicoviddic Injection submitted to the Ministry of Food and Drug Safety.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
The company stated, "Based on the initial Phase 2 clinical trial results of Zicoviddic Injection conducted at 13 domestic clinical trial institutions, we applied for domestic marketing authorization and have been under review by the Ministry of Food and Drug Safety. The Ministry recommended submitting additional clinical results that can confirm the treatment efficacy after internal review of the submitted clinical trial results and meetings with the 'COVID-19 Therapeutics Safety and Efficacy Verification Advisory Committee.' We accepted the review opinion and voluntarily withdrew the applied marketing authorization," the company explained.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
